Phenotypic characteristics and asthma severity in an East African cohort of adults and adolescents with asthma: findings from the African severe asthma project.
Administration, Inhalation
Adolescent
Adrenal Cortex Hormones
/ administration & dosage
Adult
Anti-Asthmatic Agents
/ administration & dosage
Asthma
/ drug therapy
Biomarkers
Cohort Studies
Comorbidity
Cross-Sectional Studies
Ethiopia
/ epidemiology
Female
Gastroesophageal Reflux
/ epidemiology
Humans
Kenya
/ epidemiology
Leukocyte Count
Logistic Models
Male
Middle Aged
Multivariate Analysis
Nitric Oxide
/ analysis
Phenotype
Severity of Illness Index
Smoking
/ epidemiology
Uganda
/ epidemiology
Young Adult
asthma
asthma epidemiology
asthma mechanisms
Journal
BMJ open respiratory research
ISSN: 2052-4439
Titre abrégé: BMJ Open Respir Res
Pays: England
ID NLM: 101638061
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
29
08
2019
revised:
16
01
2020
accepted:
23
01
2020
entrez:
15
2
2020
pubmed:
15
2
2020
medline:
24
7
2021
Statut:
ppublish
Résumé
The relationship between clinical and biomarker characteristics of asthma and its severity in Africa is not well known. Using the Expert Panel Report 3, we assessed for asthma severity and its relationship with key phenotypic characteristics in Uganda, Kenya and Ethiopia. The characteristics included adult onset asthma, family history of asthma, exposures (smoking and biomass), comorbidities (HIV, hypertension, obesity, tuberculosis (TB), rhinosinusitis, gastro-oesophageal disease (GERD) and biomarkers (fractional exhaled nitric oxide (FeNO), skin prick test (SPT) and blood eosinophils). We compared these characteristics on the basis of severity and fitted a multivariable logistic regression model to assess the independent association of these characteristics with asthma severity. A total of 1671 patients were enrolled, 70.7% women, with median age of 40 years. The prevalence of intermittent, mild persistent, moderate persistent and severe persistent asthma was 2.9%, 19.9%, 42.6% and 34.6%, respectively. Only 14% were on inhaled corticosteroids (ICS). Patients with severe persistent asthma had a higher rate of adult onset asthma, smoking, HIV, history of TB, FeNO and absolute eosinophil count but lower rates of GERD, rhinosinusitis and SPT positivity. In the multivariate model, Ethiopian site and a history of GERD remained associated with asthma severity. The majority of patients in this cohort presented with moderate to severe persistent asthma and the use of ICS was very low. Improving access to ICS and other inhaled therapies could greatly reduce asthma morbidity in Africa.
Identifiants
pubmed: 32054641
pii: 7/1/e000484
doi: 10.1136/bmjresp-2019-000484
pmc: PMC7047479
pii:
doi:
Substances chimiques
Adrenal Cortex Hormones
0
Anti-Asthmatic Agents
0
Biomarkers
0
Nitric Oxide
31C4KY9ESH
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Am J Respir Crit Care Med. 2010 Feb 15;181(4):315-23
pubmed: 19892860
Respirology. 2009 Aug;14(6):814-21
pubmed: 19703063
J Asthma Allergy. 2018 Aug 29;11:193-204
pubmed: 30214247
J Allergy Clin Immunol. 2005 May;115(5):897-909; quiz 910
pubmed: 15867841
Am J Epidemiol. 2006 Jun 15;163(12):1118-28
pubmed: 16707657
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
Lancet. 2012 Aug 18;380(9842):651-9
pubmed: 22901886
Lancet. 2016 Oct 29;388(10056):2115-2127
pubmed: 27609408
J Allergy Clin Immunol. 2015 Feb;135(2):299-310; quiz 311
pubmed: 25662302
Arch Intern Med. 1983 May;143(5):890-2
pubmed: 6679232
J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):570-4.e1
pubmed: 25213050
Am J Respir Crit Care Med. 2005 Feb 15;171(4):334-9
pubmed: 15557134
Clin Transl Allergy. 2013 Feb 01;3(1):3
pubmed: 23369181
Croat Med J. 2013 Dec;54(6):519-31
pubmed: 24382846
J Am Acad Dermatol. 1989 Oct;21(4 Pt 2):820-1
pubmed: 2689475
Ann Am Thorac Soc. 2014 Sep;11(7):1011-7
pubmed: 24983709
Respir Med. 2007 Oct;101(10):2076-83
pubmed: 17628463
J Appl Physiol (1985). 2010 Mar;108(3):754-9
pubmed: 19926826
Nat Med. 2012 May 04;18(5):716-25
pubmed: 22561835
Eur Respir J. 1999 Oct;14(4):902-7
pubmed: 10573240
Allergy. 2013;68(5):674-80
pubmed: 23590217
J Allergy Clin Immunol. 2000 Feb;105(2 Pt 1):224-31
pubmed: 10669840
Eur Respir J. 2014 Feb;43(2):343-73
pubmed: 24337046
J Allergy Clin Immunol. 2001 Sep;108(3):357-62
pubmed: 11544453
Arch Pediatr. 1999;6 Suppl 1:48S-54S
pubmed: 10191924
J Asthma. 2011 Apr;48(3):217-23
pubmed: 21332421
N Engl J Med. 2019 May 23;380(21):2009-2019
pubmed: 31112384
Am J Respir Crit Care Med. 2009 Jul 1;180(1):59-99
pubmed: 19535666
Lancet. 2006 Aug 26;368(9537):733-43
pubmed: 16935684
Curr Allergy Asthma Rep. 2017 Sep 1;17(10):65
pubmed: 28861721
PLoS One. 2009 Sep 25;4(9):e7146
pubmed: 19779616
Lancet Respir Med. 2018 Jan;6(1):51-64
pubmed: 28919200
Am J Respir Crit Care Med. 2012 Feb 15;185(4):356-62
pubmed: 22095547
J Allergy Clin Immunol. 2010 Nov;126(5):926-38
pubmed: 20926125
BMC Public Health. 2012 Mar 19;12:204
pubmed: 22429515